Gilead Sciences, Inc. (GILD)

Gilead Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	27,450	27,116	27,281	27,305	24,689	22,449
Revenue Growth (YoY)	1.51%	-0.60%	-0.09%	10.60%	9.98%	1.46%
Cost of Revenue	6,649	6,498	5,657	6,601	4,572	4,675
Gross Profit	20,801	20,618	21,624	20,704	20,117	17,774
Selling, General & Admin	6,147	6,090	5,673	5,246	5,151	4,381
Research & Development	5,792	5,718	4,977	4,601	4,927	4,055
Other Operating Expenses	7,285	1,205	3,644	939	5,968	5,051
Operating Expenses	19,224	13,013	14,294	10,786	16,046	13,487
Operating Income	1,577	7,605	7,330	9,918	4,071	4,287
Interest Expense / Income	968	944	935	1,001	984	995
Other Expense / Income	-492	-251	555	615	1,384	-1,890
Pretax Income	1,101	6,912	5,840	8,302	1,703	5,182
Income Tax	617	1,247	1,248	2,077	1,580	-204
Net Income	484	5,665	4,592	6,225	123	5,386
Net Income Growth	-91.33%	23.37%	-26.23%	4960.98%	-97.72%	-1.26%
Shares Outstanding (Basic)	1,247	1,248	1,255	1,256	1,257	1,270
Shares Outstanding (Diluted)	1,247	1,258	1,262	1,262	1,263	1,277
Shares Change	-1.11%	-0.32%	-	-0.08%	-1.10%	-2.37%
EPS (Basic)	0.40	4.54	3.66	4.96	0.10	4.24
EPS (Diluted)	0.35	4.50	3.64	4.93	0.10	4.22
EPS Growth	-92.10%	23.63%	-26.17%	4830.00%	-97.63%	1.20%
Free Cash Flow	7,900	7,421	8,344	10,805	7,518	8,319
Free Cash Flow Per Share	6.33	5.95	6.65	8.60	5.98	6.55
Dividend Per Share	3.020	3.000	2.920	2.840	2.720	2.520
Dividend Growth	2.72%	2.74%	2.82%	4.41%	7.94%	10.53%
Gross Margin	75.78%	76.04%	79.26%	75.82%	81.48%	79.18%
Operating Margin	5.74%	28.05%	26.87%	36.32%	16.49%	19.10%
Profit Margin	1.76%	20.89%	16.83%	22.80%	0.50%	23.99%
Free Cash Flow Margin	28.78%	27.37%	30.59%	39.57%	30.45%	37.06%
Effective Tax Rate	56.04%	18.04%	21.37%	25.02%	92.78%	-3.94%
EBITDA	4,812	10,549	8,878	11,353	4,167	7,581
EBITDA Margin	17.53%	38.90%	32.54%	41.58%	16.88%	33.77%
Depreciation & Amortization	2,743	2,693	2,103	2,050	1,480	1,404
EBIT	2,069	7,856	6,775	9,303	2,687	6,177
EBIT Margin	7.54%	28.97%	24.83%	34.07%	10.88%	27.52%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).